Health
EBMT trial shows improvements in treatment of Severe Aplastic Anaemia – EurekAlert
The European Society for Blood and Marrow Transplantation (EBMT), Europe’s collaborative peer network of professionals working in the field of stem cell transplantation and cellular therapy, announced today the results of the phase III RACE trial during EBMTs…
The European Society for Blood and Marrow Transplantation (EBMT), Europe’s collaborative peer network of professionals working in the field of stem cell transplantation and cellular therapy, announced today the results of the phase III RACE trial during EBMTs virtual 46th Annual Meeting. Preliminary data show that adding Eltrombopag to standard immunosuppressive treatment is safe and increases response rates in patients with Severe Aplastic Anaemia (SAA).
SAA is a condition in which the bone m…
-
General20 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
Business24 hours agoUp 20% in 2 days, are Codan shares a buy, hold or sell?
-
General18 hours agoEveryday AI use brings a hidden climate cost
-
Noosa News23 hours agoBoat crash in Helensvale on the Gold Coast leaves man with life-threatening burns and another one injured